SNDX
NASDAQ · Biotechnology
Syndax Pharmaceuticals Inc
$18.07
+0.45 (+2.55%)
Performance
1D
—
1W
—
1M
—
3M
-8.78%
6M
-23.07%
1Y
-24.71%
YTD
-24.71%
Open$17.74
Previous Close$17.62
Day High$18.45
Day Low$17.39
52W High$25.59
52W Low$12.99
Volume—
Avg Volume1.58M
Market Cap1.58B
P/E Ratio—
EPS$-2.52
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$20.42
Below
RSI (14)
34.3
Neutral
Analyst Ratings
Strong Buy
19 analysts
Price Target
+35.5% upside
Current
$18.07
$18.07
Target
$24.49
$24.49
$15.15
$24.49 avg
$32.88
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 172.78M | 42.66M | 332.47M |
| Net Income | -286,132,994 | -516,701,989 | -96,723,913 |
| Profit Margin | -165.6% | -1,278.8% | -29.1% |
| EBITDA | -273,758,126 | -581,608,963 | -125,567,751 |
| Free Cash Flow | — | — | -63,645,585 |
| Rev Growth | — | -44.7% | -3.0% |
| Debt/Equity | 5.32 | 1.19 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |